The landscape of laboratory-developed tests (LDTs) is fraught with uncertainty, particularly as regulatory bodies like the U.S. Food and Drug Administration (FDA) continue to explore oversight mechanisms.
For the full article click here: How small, high-complexity testing labs can adapt to FDA LDT regulatory shifts